2m 2m 2m 2m 2m 2m 2m
JAGUAR HEALTH (JAGX)
NASDAQ
$2.15-$0.10 (-4.44%)
Price as of Jul 14, 2026 4:00 AM EDT- $11.2MMarket Cap
- -97.04%1-Year Change
- BiotechnologyIndustry
JAGUAR HEALTH (JAGX)
$2.15-$0.10 (-4.44%)
JAGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.25 | ||
Change | -$0.06 (-2.60%) | ||
Open | $2.25 | ||
High | $2.28 | ||
Low | $2.22 | ||
Previous Close | $2.31 | ||
Volume | 7,512 | ||
30-Day Average Volume | 85,388 | ||
1-Week Change | -19.93% | ||
1-Month Change | -16.36% | ||
1-Year Change | -97.04% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 4.9M | ||
Total Assets | $37.4M | ||
Market Cap | $11.2M | ||
Enterprise Value | $37.1M | ||
Period: QTR TTM FY | |||
Revenue | $19.0M | ||
Net Income | $8.7M | ||
Free Cash Flow | $8.8M | ||
EBIT | $9.4M | ||
EBITDA | $9.9M | ||
Net Working Capital | -$20.5M | ||
EPS | -$476.00 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | 2 | ||
P/B | -1 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | 1 | ||
Price/Operating Cash Flow | 1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 04/30/2026 | ||
Earnings & Revenue